• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用分数激光和替比嘧啶软膏治疗鳞状细胞癌和基底细胞癌。

Utilizing fractional lasers and tirbanibulin ointment to treat squamous and basal cell carcinomas.

机构信息

, 121 E 60 St, 2D, New York, NY, 10022, USA.

出版信息

Arch Dermatol Res. 2024 Oct 14;316(10):683. doi: 10.1007/s00403-024-03423-0.

DOI:10.1007/s00403-024-03423-0
PMID:39400600
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11473590/
Abstract

Keratinocyte carcinoma is the most common form of cancer in the United States. Often treated by surgical excision, electrodessication and curettage, or Mohs surgery, treatment can frequently leave patients with a scar and can be time consuming and inconvenient for both patients and healthcare providers. Utilizing non-ablative fractional laser therapy followed by tirbanibulin ointment, we treated 30 basal and/or squamous cell carcinomas on 23 patients over the age of 50 with varying skin types. Multiple areas of the face and body, and carcinomas at differing stages, were treated. We maximized the depth of penetration of the fractional laser by using bulk heating methods while simultaneously optimizing cosmetic results. This is an ongoing study as we continue to track the progress of our participants. Thus far, no clinical or histological recurrence of carcinoma has been found in any of the treated sites.

摘要

角化细胞癌是美国最常见的癌症类型。通常通过手术切除、电干燥和刮除术或莫氏手术进行治疗,这些治疗方法常常会给患者留下疤痕,而且对患者和医疗保健提供者来说既耗时又不方便。我们利用非消融性的分束激光治疗,随后使用替比嘧啶软膏,对 23 名 50 岁以上、不同皮肤类型的患者的 30 例基底细胞癌和/或鳞状细胞癌进行了治疗。治疗了面部和身体的多个部位,以及不同阶段的癌。我们通过使用体加热方法最大化分束激光的穿透深度,同时优化美容效果。这是一项正在进行的研究,因为我们继续跟踪参与者的进展情况。到目前为止,在任何治疗部位都没有发现癌的临床或组织学复发。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9117/11473590/0fafc7dc3c39/403_2024_3423_Fig18_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9117/11473590/5743b420053e/403_2024_3423_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9117/11473590/8cf6da4529bb/403_2024_3423_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9117/11473590/dc80194c5d3f/403_2024_3423_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9117/11473590/0bbfb3ba61de/403_2024_3423_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9117/11473590/6a3410fe5fc3/403_2024_3423_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9117/11473590/8b3701555637/403_2024_3423_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9117/11473590/54e3c2a2eb54/403_2024_3423_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9117/11473590/fe275ba02a71/403_2024_3423_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9117/11473590/1263e0746f86/403_2024_3423_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9117/11473590/c7bf113a0dd6/403_2024_3423_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9117/11473590/988ce652c499/403_2024_3423_Fig11_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9117/11473590/5941f6f49b91/403_2024_3423_Fig12_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9117/11473590/23a45d4f3e90/403_2024_3423_Fig13_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9117/11473590/dcbdd5628cd1/403_2024_3423_Fig14_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9117/11473590/51222d358146/403_2024_3423_Fig15_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9117/11473590/559db4ca94b6/403_2024_3423_Fig16_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9117/11473590/16c5fda9b9bf/403_2024_3423_Fig17_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9117/11473590/0fafc7dc3c39/403_2024_3423_Fig18_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9117/11473590/5743b420053e/403_2024_3423_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9117/11473590/8cf6da4529bb/403_2024_3423_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9117/11473590/dc80194c5d3f/403_2024_3423_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9117/11473590/0bbfb3ba61de/403_2024_3423_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9117/11473590/6a3410fe5fc3/403_2024_3423_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9117/11473590/8b3701555637/403_2024_3423_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9117/11473590/54e3c2a2eb54/403_2024_3423_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9117/11473590/fe275ba02a71/403_2024_3423_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9117/11473590/1263e0746f86/403_2024_3423_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9117/11473590/c7bf113a0dd6/403_2024_3423_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9117/11473590/988ce652c499/403_2024_3423_Fig11_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9117/11473590/5941f6f49b91/403_2024_3423_Fig12_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9117/11473590/23a45d4f3e90/403_2024_3423_Fig13_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9117/11473590/dcbdd5628cd1/403_2024_3423_Fig14_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9117/11473590/51222d358146/403_2024_3423_Fig15_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9117/11473590/559db4ca94b6/403_2024_3423_Fig16_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9117/11473590/16c5fda9b9bf/403_2024_3423_Fig17_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9117/11473590/0fafc7dc3c39/403_2024_3423_Fig18_HTML.jpg

相似文献

1
Utilizing fractional lasers and tirbanibulin ointment to treat squamous and basal cell carcinomas.利用分数激光和替比嘧啶软膏治疗鳞状细胞癌和基底细胞癌。
Arch Dermatol Res. 2024 Oct 14;316(10):683. doi: 10.1007/s00403-024-03423-0.
2
Non-melanoma skin cancer: United Kingdom National Multidisciplinary Guidelines.非黑色素瘤皮肤癌:英国国家多学科指南
J Laryngol Otol. 2016 May;130(S2):S125-S132. doi: 10.1017/S0022215116000554.
3
An Analysis of Laser Therapy for the Treatment of Nonmelanoma Skin Cancer.激光治疗非黑色素瘤皮肤癌的分析
Dermatol Surg. 2017 May;43(5):615-624. doi: 10.1097/DSS.0000000000001048.
4
Treatment of superficial basal cell carcinoma and squamous cell carcinoma in situ on the trunk and extremities with ablative fractional laser-assisted delivery of topical fluorouracil.采用剥脱性分次激光辅助局部外用氟尿嘧啶治疗躯干和四肢的浅表基底细胞癌和原位鳞状细胞癌。
J Am Acad Dermatol. 2015 Mar;72(3):558-60. doi: 10.1016/j.jaad.2014.11.033.
5
Cutaneous carcinoma of the head and neck: management of massive and previously uncontrolled lesions.头颈部皮肤癌:巨大且先前未得到控制的病变的管理
Laryngoscope. 1983 Jan;93(1):87-105. doi: 10.1288/00005537-198301000-00017.
6
Chemoprevention of Basal and Squamous Cell Carcinoma With a Single Course of Fluorouracil, 5%, Cream: A Randomized Clinical Trial.氟尿嘧啶 5%乳膏单次疗程用于基底细胞和鳞状细胞癌的化学预防:一项随机临床试验。
JAMA Dermatol. 2018 Feb 1;154(2):167-174. doi: 10.1001/jamadermatol.2017.3631.
7
Basal cell carcinoma and squamous cell carcinoma. Recognition and treatment.基底细胞癌和鳞状细胞癌。识别与治疗。
Med Clin North Am. 1986 Jan;70(1):95-107. doi: 10.1016/s0025-7125(16)30971-3.
8
Defining recurrence of nonmelanoma skin cancer after Mohs micrographic surgery: Report of the American College of Mohs Surgery Registry and Outcomes Committee.Mohs 显微外科手术后非黑素瘤皮肤癌复发的定义:美国 Mohs 外科学会注册和结果委员会的报告。
J Am Acad Dermatol. 2016 Nov;75(5):1022-1031. doi: 10.1016/j.jaad.2016.06.047. Epub 2016 Aug 18.
9
Interventions for basal cell carcinoma of the skin.皮肤基底细胞癌的干预措施。
Cochrane Database Syst Rev. 2020 Nov 17;11(11):CD003412. doi: 10.1002/14651858.CD003412.pub3.
10
Basal Cell and Cutaneous Squamous Cell Carcinomas: Diagnosis and Treatment.基底细胞和皮肤鳞状细胞癌:诊断与治疗。
Am Fam Physician. 2020 Sep 15;102(6):339-346.

引用本文的文献

1
Comparison of clinical effects and patient satisfaction between ultra-pulsed CO₂ laser treatment and surgical excision in patients with facial basal cell carcinoma.超脉冲二氧化碳激光治疗与手术切除治疗面部基底细胞癌患者的临床效果及患者满意度比较
Front Surg. 2025 Aug 14;12:1628257. doi: 10.3389/fsurg.2025.1628257. eCollection 2025.

本文引用的文献

1
Nonablative Fractional Laser Treatment Is Associated With a Decreased Risk of Subsequent Facial Keratinocyte Carcinoma Development.非剥脱性分次激光治疗与后续面部角质形成细胞癌发生风险降低相关。
Dermatol Surg. 2023 Feb 1;49(2):149-154. doi: 10.1097/DSS.0000000000003672. Epub 2022 Dec 6.
2
Tirbanibulin for Actinic Keratosis: Insights into the Mechanism of Action.替拉替尼治疗光化性角化病:作用机制洞察
Clin Cosmet Investig Dermatol. 2022 Nov 16;15:2495-2506. doi: 10.2147/CCID.S374122. eCollection 2022.
3
Cutaneous Squamous Cell Carcinoma: From Pathophysiology to Novel Therapeutic Approaches.
皮肤鳞状细胞癌:从病理生理学到新型治疗方法
Biomedicines. 2021 Feb 9;9(2):171. doi: 10.3390/biomedicines9020171.
4
Nonablative fractional laser therapy for treatment of actinic keratosis with 3-months follow-up.
J Cosmet Dermatol. 2020 Nov;19(11):2893-2897. doi: 10.1111/jocd.13350. Epub 2020 Mar 1.
5
Lidocaine-induced potentiation of thermal damage in skin and carcinoma cells.利多卡因诱导的皮肤和癌细胞热损伤增强。
Lasers Surg Med. 2019 Jan;51(1):88-94. doi: 10.1002/lsm.23027. Epub 2018 Oct 15.
6
Heat transfer analysis of skin during thermal therapy using thermal wave equation.基于热波方程的热疗过程中皮肤传热分析
J Therm Biol. 2017 Feb;64:7-18. doi: 10.1016/j.jtherbio.2016.12.007. Epub 2016 Dec 18.
7
Heat shock proteins: a therapeutic target worth to consider.热休克蛋白:一个值得考虑的治疗靶点。
Vet World. 2015 Jan;8(1):46-51. doi: 10.14202/vetworld.2015.46-51. Epub 2015 Jan 13.
8
A comprehensive examination of topographic thickness of skin in the human face.对面部皮肤地形图厚度的全面检查。
Aesthet Surg J. 2015 Nov;35(8):1007-13. doi: 10.1093/asj/sjv079.
9
Characteristics of the Aging Skin.衰老皮肤的特征。
Adv Wound Care (New Rochelle). 2013 Feb;2(1):5-10. doi: 10.1089/wound.2011.0356.
10
Clinical variants, stages, and management of basal cell carcinoma.基底细胞癌的临床变异型、分期及治疗
Indian Dermatol Online J. 2013 Jan;4(1):12-7. doi: 10.4103/2229-5178.105456.